Safety and efficacy of the terminal complement Inhibitor Eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : The AEGIS clinical trial.

Bibliographic Information

Title
Safety and efficacy of the terminal complement Inhibitor Eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : The AEGIS clinical trial.
Author
金倉譲(1番目), 西村純一(10番目), 他14名

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1010000782049099264
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top